← THE EVIDENCE INDEXThe Study Library.
8,456 peer-reviewed studies, each with a short note written from its published abstract: what kind of study it was, who took part, what was measured and what the authors reported. Observational studies show associations, not proof.
Showing studies that examined garlic. Clear
Pooled results from many studies on one question.
3 studies
2019 / Meta-analysis of randomized controlled trials
A meta-analysis of 16 randomized controlled trials evaluated garlic doses between 12 and 3,600 mg daily for 2 to 52 weeks. Garlic administration lowered serum C-reactive protein (WMD -0.61 mg/L, 95% CI -1.12 to -0.11), IL-6 (WMD -0.73 ng/L, 95% CI -1.06 to -0.40), and TNF (WMD -0.26 ng/L, 95% CI -0.41 to -0.12). Conversely, garlic exerted no significant effect on adiponectin or leptin levels.
Darooghegi Mofrad M, Milajerdi A, Koohdani F, et al. J Nutr, 2019. PMID 30949665
2018 / Systematic review
A systematic review evaluated 113 controlled human intervention trials testing 17 putative superfoods on risk markers for metabolic syndrome. Studied foods included garlic (21 trials), flaxseed (22 trials), cocoa (16 trials), blueberries (8 trials), and strawberries (7 trials). The authors found limited overall evidence for beneficial impacts on waist circumference, BMI, blood pressure, blood glucose, or lipids, citing inconsistent findings across trials and a small number of studies for many evaluated foods.
van den Driessche JJ, Plat J, Mensink RP Food Funct, 2018. PMID 29557436
2014 / Systematic review of randomized controlled trials
A systematic review identified only one eligible trial evaluating garlic supplementation for the common cold. That study randomized 146 participants to daily garlic or placebo for 12 weeks, finding fewer colds in the garlic arm (24 versus 65, P < 0.001) and fewer sick days (111 versus 366). Days to recovery were comparable (4.63 versus 5.63 days), leaving insufficient evidence to draw firm conclusions.
Lissiman E, Bhasale AL, Cohen M Cochrane Database Syst Rev, 2014. PMID 25386977